Amazon Expands Healthcare in India Amid AI-Driven Workforce Reshaping

Amazon's stock dipped 1.33% to $209.69 as the company unveiled plans to deepen its healthcare footprint in India through diagnostic test bookings, partnering with Orange Health. The move follows earlier launches of online pharmacy and teleconsultation services, targeting what Amazon describes as a "long-term opportunity" in India's burgeoning healthcare sector.

CEO Andy Jassy issued a stark warning about AI's disruptive potential, signaling corporate job cuts as Amazon accelerates automation. The company plans to invest $105 billion in AI infrastructure by 2025—a commitment that dwarfs peers like Microsoft—while simultaneously allocating $233 million for Indian operational expansion.

Despite a 4.42% year-to-date decline, AMZN shares have delivered a 97.41% return over three years, reflecting the market's long-term confidence in Amazon's dual strategy of sectoral expansion and technological dominance.